Feeds:
Posts
Comments

Archive for the ‘CuraGen Corporation (NASDAQ:CRGN)’ Category

CuraGen Corporation (NASDAQ:CRGN) Q1 update; Greenbackd exits

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on May 18, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has filed its 10Q for the period ended March 31, 2009. CRGN’s stock has risen strongly over the last few months, and is now trading at $1.02, giving it a market capitalization slightly higher than our estimate of its liquidation value. Accordingly, we’re going to take this opportunity to exit. The stock [...]

Read Full Post »

List of activist investments for March

Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Stocks, tagged , , , , on April 13, 2009 | Leave a Comment »

The Official Activist Investing Blog has published its list of activist investments for March (links are to the relevant post archive for our open positions):

Ticker
Company
Investor

ACTL
Actel Corp
Ramius Capital

AGYS
Agilysys Inc
Ramius Capital

AMLN
Amylin Pharmaceuticals
Eastbourne Capital

ASPM
Aspect Medical Systems
First Manhattan Co

ASPM
Aspect Medical Systems
Coghill Capital

AVCA
Advocat Inc.
Bristol Investment Fund

AVGN
Avigen Inc
Biotechnology Value Fund

BARI
Bancorp Rhode Island
Financial Edge Fund

BASI
Bioanalytical Systems
Thomas Harenburg

BBI
Blockbuster Inc.
Mark Wattles

BBW
Build-A-Bear Workshop
Crescendo Capital

BNV
Beverly National [...]

Read Full Post »

CuraGen Corporation (NASDAQ:CRGN) 10K update

Posted in CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , , on March 13, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has filed its 10K for the fiscal year ended December 31, 2008.
We’ve been following CRGN since January 20, 2009 (see our post archive here) because it is a net cash stock with an investor, DellaCamera Capital Management, pushing the company to seek “alternative deployment of [its] capital.” DellaCamera Capital Management has since [...]

Read Full Post »

DellaCamera Capital Management ups stake in CRGN

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on March 6, 2009 | Leave a Comment »

DellaCamera Capital Management has increased its stake in CuraGen Corporation (NASDAQ:CRGN) from 5.6% to 6.5% and nominated two candidates to the board.
We’ve been following CRGN since January 20, 2009 (see our post archive here) because it is a net cash stock with an investor, DellaCamera Capital Management, pushing the company to seek “alternative deployment of [...]

Read Full Post »

Greenbackd Portfolio Q1 performance and update

Posted in ARC Wireless Solutions (NASDAQ:ARCW), About, Arrhythmia Research Technology Inc (AMEX:HRT), Audiovox Corporation (NASDAQ:VOXX), Autobytel (NASDAQ:ABTL), Avigen (NASDAQ:AVGN), Axcelis Technologies Inc (NASDAQ:ACLS), Barnwell Industries (AMEX:BRN), Borders Group (NYSE:BGP), Chromcraft Revington (AMEX:CRC), Cobra Electronics Corporation (NASDAQ:COBR), CuraGen Corporation (NASDAQ:CRGN), Ditech Networks Inc (NASDAQ:DITC), Greenbackd, Greenbackd Portfolio, Ikanos Communications Inc (NASDAQ:IKAN), InFocus Corporation (NASDAQ:INFS), Kona Grill Inc (NASDAQ:KONA), MathStar Inc (OTC:MATH), Multimedia Games Inc (NASDAQ:MGAM), Network Engines Inc (NASDAQ:NENG), Neurobiological Technologies Inc (NASDAQ:NTII), Northstar Neuroscience Inc (NASDAQ:NSTR), OrthoLogic Corporation (NASDAQ:CAPS), Soapstone Networks Inc (NASDAQ:SOAP), Stocks, ValueVision Media (NASDAQ:VVTV), Zale Corporation (NYSE:ZLC), tagged , , , , , , , , , , , , , , , , on March 2, 2009 | 10 Comments »

March 1, 2009 marked the end of Greenbackd’s first quarter, so we thought we’d take the opportunity to update you on the performance of the Greenbackd Portfolio and the positions in the portfolio, discuss some changes in our valuation methodology since our first post and outline the future direction of Greenbackd.com.
First quarter performance of the [...]

Read Full Post »

CRGN to evaluate strategic options

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on February 24, 2009 | Leave a Comment »

CuraGen Corporation (NASDAQ:CRGN) has announced that it is considering strategic alternatives to enhance shareholder value including selling or licensing CR011, acquiring additional assets or business lines, or selling the company.
We started following CRGN on January 20 this year because it is a net cash stock with an investor, DellaCamera Capital Management, disclosing a 5.6% holding [...]

Read Full Post »

List of activist investments for January

Posted in Activist Investors, Avigen (NASDAQ:AVGN), Biotechnology Value Fund, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Dolphin Limited Partnership, GAMCO, Icagen Inc (NASDAQ:ICGN), Mill Road Capital, Multimedia Games Inc (NASDAQ:MGAM), Nery Capital Partners, Stocks, tagged , , , , , , , , on February 10, 2009 | Leave a Comment »

The Official Activist Investing Blog has published its list of activist investments for January (the investments with links are to our latest update at the time of this post):

Ticker
Company
Activist Investor

ABVA
Alliance Bankshares Corp
John Edgemond

AMLN
Amylin Pharmaceuticals
Carl Icahn; Eastbourne Capital

AVGN
Avigen Inc.
Biotechnology Value Fund

BIOD
Biodel Inc
Moab Partners

BKS
Barnes & Noble, Inc
Yucaipa Companies

CHUX
O’Charley’s Inc
Crescendo Partners

CITZ
CFS Bancorp
Financial Edge Fund

CLCT
Collectors Universe
Shamrock Activist Fund

CNBC
Center Bancorp
Lawrence [...]

Read Full Post »

CuraGen Corporation (NASDAQ:CRGN)

Posted in Activist Investors, CuraGen Corporation (NASDAQ:CRGN), DellaCamera Capital Management, Net Cash Stocks, Stocks, tagged , , , on January 20, 2009 | 1 Comment »

CuraGen Corporation (NASDAQ:CRGN) is a net cash stock with an investor, DellaCamera Capital Management, disclosing a 5.6% holding in a 13D filed on January 15. At its $0.67 closing price Friday, CRGN’s market capitalization is $38.5M. We estimate CRGN’s net cash value to be 60% higher at $62M or $1.07 per share. The company is [...]

Read Full Post »